- Home
- SXTP vs INM Comparison
SXTP vs INM Comparison
Compare SXTP & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- INM
- Stock Information
- Founded
- SXTP 2010
- INM 1981
- Country
- SXTP United States
- INM Canada
- Employees
- SXTP N/A
- INM N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- SXTP Health Care
- INM Health Care
- Exchange
- SXTP Nasdaq
- INM Nasdaq
- Market Cap
- SXTP 2.4M
- INM 2.3M
- IPO Year
- SXTP 2023
- INM N/A
- Fundamental
- Price
- SXTP $0.45
- INM $3.12
- Analyst Decision
- SXTP Hold
- INM
- Analyst Count
- SXTP 1
- INM 0
- Target Price
- SXTP N/A
- INM N/A
- AVG Volume (30 Days)
- SXTP 5.8M
- INM 84.1K
- Earning Date
- SXTP 03-31-2025
- INM 02-12-2025
- Dividend Yield
- SXTP N/A
- INM N/A
- EPS Growth
- SXTP N/A
- INM N/A
- EPS
- SXTP N/A
- INM N/A
- Revenue
- SXTP $462,612.00
- INM $4,832,013.00
- Revenue This Year
- SXTP $141.35
- INM N/A
- Revenue Next Year
- SXTP $175.16
- INM N/A
- P/E Ratio
- SXTP N/A
- INM N/A
- Revenue Growth
- SXTP 128.99
- INM N/A
- 52 Week Low
- SXTP $0.41
- INM $2.42
- 52 Week High
- SXTP $7.20
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- SXTP 33.01
- INM 37.82
- Support Level
- SXTP $0.47
- INM $3.03
- Resistance Level
- SXTP $0.67
- INM $3.48
- Average True Range (ATR)
- SXTP 0.10
- INM 0.20
- MACD
- SXTP 0.00
- INM 0.05
- Stochastic Oscillator
- SXTP 12.96
- INM 35.59
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.